The present paper describes the synthesis of a series of 8-(cyclopentyloxy)phenyl-xanthines and their evaluation for affinity for A1 and A2 adenosine receptors using radioligand binding assays. The effects of moving the cyclopentyloxy substituent with or without an ortho methoxy group on the various positions of the 8-phenyl ring have been studied. The vanilloid based xanthines 8-[4-(cyclopentyloxy)-3-methoxyphenyl]-1,3-dimethylxanthine (6a) (K(i)= 100 nM) and 8-[(4-cyclopentyloxy)-3-methoxyphenyl] -3-methyl-1-propylxanthine (12) (K(i) = 150 nM) displayed the highest affinity at A2A receptors as well as over 1000 fold selectivity over the A1 adenosine receptor subtype
A new series of 9-methyladenines, bearing different bulky groups at the 8-position, were prepared an...
Novel 3,8- and 8,9-disubstituted N6-cyclopentyladenine derivatives were synthesised in moderate over...
Mol. modeling studies, including the comparative mol. field anal. (CoMFA) method, on 52 antagonists ...
The present paper describes the synthesis of a series of 8-(cyclopentyloxy)phenyl-xanthines and thei...
A new series of 8-(substituted-phenyl)xanthines have been synthesized and compounds were evaluated f...
Based on a previous report that a series of 8-(phenoxymethyl)-xanthines may be promising leads for t...
A new series of 1H-imidazol-1-yl substituted 8-phenylxanthine analogs has been synthesized to study ...
The activity of a series of 1,3-dipropyl-xanthines bearing C8-cycloalkyl substituents as antagonists...
Adenosine A1 receptors are attracting great interest as drug targets for their role in cognitive def...
The receptor binding affinity data to adenosine A(1) and A(2a) receptors of a wide series of 8-ethen...
7-β-D-Ribofuranosylxanthine, a previously unreported isomer of xanthosine, was prepared in four step...
For the development of new analogues of the highly affine and selective radioligand 8-cyclopentyl-3-...
The synthesis and biological evaluation of N6, C8-disubstituted derivatives of adenosine as potentia...
Objectives 8-Cyclopentyl-3-(3-[18F]fluoropropyl)-1-propylxanthine ([18F]CPFPX) is an established rec...
The adenosine A2A receptor is considered to be an important target for the development of new therap...
A new series of 9-methyladenines, bearing different bulky groups at the 8-position, were prepared an...
Novel 3,8- and 8,9-disubstituted N6-cyclopentyladenine derivatives were synthesised in moderate over...
Mol. modeling studies, including the comparative mol. field anal. (CoMFA) method, on 52 antagonists ...
The present paper describes the synthesis of a series of 8-(cyclopentyloxy)phenyl-xanthines and thei...
A new series of 8-(substituted-phenyl)xanthines have been synthesized and compounds were evaluated f...
Based on a previous report that a series of 8-(phenoxymethyl)-xanthines may be promising leads for t...
A new series of 1H-imidazol-1-yl substituted 8-phenylxanthine analogs has been synthesized to study ...
The activity of a series of 1,3-dipropyl-xanthines bearing C8-cycloalkyl substituents as antagonists...
Adenosine A1 receptors are attracting great interest as drug targets for their role in cognitive def...
The receptor binding affinity data to adenosine A(1) and A(2a) receptors of a wide series of 8-ethen...
7-β-D-Ribofuranosylxanthine, a previously unreported isomer of xanthosine, was prepared in four step...
For the development of new analogues of the highly affine and selective radioligand 8-cyclopentyl-3-...
The synthesis and biological evaluation of N6, C8-disubstituted derivatives of adenosine as potentia...
Objectives 8-Cyclopentyl-3-(3-[18F]fluoropropyl)-1-propylxanthine ([18F]CPFPX) is an established rec...
The adenosine A2A receptor is considered to be an important target for the development of new therap...
A new series of 9-methyladenines, bearing different bulky groups at the 8-position, were prepared an...
Novel 3,8- and 8,9-disubstituted N6-cyclopentyladenine derivatives were synthesised in moderate over...
Mol. modeling studies, including the comparative mol. field anal. (CoMFA) method, on 52 antagonists ...